Growth Metrics

Veracyte (VCYT) Depreciation & Amortization (CF) (2016 - 2025)

Veracyte's Depreciation & Amortization (CF) history spans 14 years, with the latest figure at $5.3 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 15.27% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $21.4 million, down 8.71%, while the annual FY2025 figure was $21.4 million, 8.71% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $5.3 million at Veracyte, up from $5.3 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $7.3 million in Q3 2023 and bottomed at $2.6 million in Q1 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $6.2 million (2021), against an average of $5.9 million.
  • The largest annual shift saw Depreciation & Amortization (CF) soared 216.25% in 2021 before it decreased 19.73% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $6.4 million in 2021, then grew by 2.37% to $6.6 million in 2022, then dropped by 3.36% to $6.3 million in 2023, then dropped by 1.31% to $6.3 million in 2024, then decreased by 15.27% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Depreciation & Amortization (CF) are $5.3 million (Q4 2025), $5.3 million (Q3 2025), and $5.5 million (Q2 2025).